Company Profile
Alcon Inc. Stock Price, News & Analysis
- Ticker:
- ALC
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- Switzerland and listed in the U
Stock performance
69.54 USD (-1.46%)
Close
Last updated: August 6, 2026
31.3B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ALC closed down 1.46% at $69.54. No new same-company headline was identified in the current news window.
Company overview
Business overview
Alcon is a global eye care company focused on surgical and vision-care products. Its business spans cataract surgery, contact lenses, and related ophthalmic devices rather than biotech therapeutics.
Geographic Base and Sector Classification
Headquartered in Switzerland and listed in the U.S. as an ADR, Alcon has a global commercial footprint. It belongs to ophthalmic medical devices and vision care, not biotechnology.
Business Model Characteristics
The company generates value through procedure-linked surgical products, consumables, and vision-care platforms. Investors watch surgical demand, lens adoption, and the durability of recurring eye-care revenue.
Position Within the Biotechnology Landscape
Alcon sits outside biotech and inside the broader healthcare technology stack. It is more influenced by procedure volumes and consumer/clinical demand than by drug-development catalysts.
Future catalysts
Alcon should be tracked for dry-eye launches, cataract growth, and any presbyopia or retina pipeline step that expands the eye-care story. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alcon Inc. (ALC)?
Alcon Inc. (ALC) most recently closed at 69.54 USD, a -1.46% move versus the previous session.
What is the market cap of Alcon Inc. (ALC)?
Alcon Inc. currently has a market capitalization of 31.3B USD on BioPharmSignal.
What does Alcon Inc. do?
Alcon is a global eye care company focused on surgical and vision-care products. Its business spans cataract surgery, contact lenses, and related ophthalmic devices rather than biotech therapeutics.
On which exchange is ALC stock listed?
Alcon Inc. (ALC) is associated with NYSE, Switzerland and listed in the U, MedTech.
What is Alcon?
Alcon should be tracked for dry-eye launches, cataract growth, and any presbyopia or retina pipeline step that expands the eye-care story.
Which conditions is Alcon Inc. targeting with Alcon?
Alcon should be tracked for dry-eye launches, cataract growth, and any presbyopia or retina pipeline step that expands the eye-care story.
How does Alcon Inc. describe recent progress with Alcon?
Alcon should be tracked for dry-eye launches, cataract growth, and any presbyopia or retina pipeline step that expands the eye-care story.
What future catalysts are investors watching for Alcon Inc.?
Alcon should be tracked for dry-eye launches, cataract growth, and any presbyopia or retina pipeline step that expands the eye-care story. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers...